ISRCTN35836727已完成未知
Developing better care for the elderly patients with walking disability due to degenerative lumbar spine stenosis
Record Provided by the NHSTCT Register - 2006 Update - Department of Health0 个研究点目标入组 20 人开始时间: 2006年9月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients 65 and over
- •2. Unilateral or bilateral neurogenic claudication (NC), ie exercise induced leg pain on walking, relieved in sitting
- •3. Patient reported limitation of walking tolerance due to symptoms of NC
排除标准
- •1. Cognitive impairment preventing full understanding or participation in the study
- •2. Evidence of medical conditions such as hip/leg pathology or peripheral vascular disease, which may mimic NC or prevent participation in a shuttle walking test
- •3. Severe or worsening neurological status
- •4. Signs/symptoms of cauda equina compression, inflammatory joint disease, signs/symptoms of sinister pathology (unexplained weight loss, unremitting/night-time pain, history of cancer), which may require urgent surgical opinion. This will be determined through subjective and objective examination of patients by the recruiting researcher at the point of screening
- •5. Exclusion criterion for Home Trial Pilot phase only: previous use of walking aid
研究者
相似试验
招募中
不适用
Improving health and well-being of elderly patients through nurse-led discharge plan and follow-up care: a Randomised Controlled TrialWell-being in the elderlySLCTR/2017/011niversity of Sri Jayewardenepura
已完成
Unknown
Improving the long-term care of patients who have had bariatric surgery: PROMISE CARE studyObesity - post-bariatric surgery follow-up careSurgeryISRCTN13573642niversity of East Anglia52
已完成
不适用
ursing intervention for older patients who are discharged home from Emergency DepartmentISRCTN08788893niversity Hospital of Amager (Denmark)300
进行中（未招募）
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-BESaarland University388
进行中（未招募）
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-002272-27-ATSaarland University388